文献速递脑血管病

卵圆孔未闭与病因明确卒中复发风险的关系

Patent Foramen Ovale and Risk of Recurrence in Stroke of Determined Etiology.
PubMed 文献 · Ann Neurol · 2022-07-15

该研究纳入2314例病因明确且接受经食管超声心动图检查的卒中患者,其中827例(35.7%)存在卵圆孔未闭(PFO)。中位随访4.4年,202例(8.7%)复发脑梗死;多因素分析显示PFO与未PFO者复发风险无显著差异(HR=0.86,95%CI 0.64-1.17,p=0.339),但年龄<65岁患者中PFO与复发风险降低独立相关(HR=0.41,95%CI 0.20-0.85,校正p=0.016),PASCAL分类为很可能PFO相关卒中者复发风险显著低于无PFO者(HR=0.31,95%CI 0.10-0.97,p=0.044)。

要点

  • 病因明确卒中患者中PFO患病率为35.7%(827/2314)。
  • 整体队列中PFO与无PFO者复发风险无显著差异(HR=0.86,95%CI 0.64-1.17,p=0.339)。
  • 年龄<65岁患者中PFO与复发风险降低独立相关(HR=0.41,95%CI 0.20-0.85,校正p=0.016)。

核心结论

  • 考虑到PFO相关卒中复发风险总体较低,PFO可能是一些病因明确卒中患者的实际病因,尤其是年轻患者或具有很可能PFO相关卒中特征者。

研究设计与样本

  • 研究纳入连续接受经食管超声心动图检查的病因明确卒中患者,比较有无PFO及按PASCAL分类的复发性脑梗死发生率。

主要发现

  • 2314例患者中827例(35.7%)有PFO,中位随访4.4年期间202例(8.7%)复发脑梗死。
  • 多因素改良Cox回归分析显示,有PFO与无PFO患者复发脑梗死风险无显著差异(HR=0.86,95%CI 0.64-1.17,p=0.339)。
  • 交互分析显示PFO在年龄<65岁患者中效应显著(交互作用校正p=0.090)。
  • 年龄<65岁患者中PFO与复发性脑梗死风险降低独立相关(HR=0.41,95%CI 0.20-0.85,校正p=0.016)。
  • PASCAL分类为很可能PFO相关卒中者复发脑梗死风险显著低于无PFO者(HR=0.31,95%CI 0.10-0.97,p=0.044)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patent foramen ovale (PFO) is often found in stroke patients with determined etiologies. PFO may be the actual cause of stroke in some of them. We determined whether the risk of recurrent ischemic stroke differs with PFO status in stroke patients with determined etiologies. METHODS: This study included consecutive patients with stroke of determined etiology who underwent transesophageal echocardiography. We compared the rates of recurrent cerebral infarction in patients with versus without PFO, and according to PFO-Associated Stroke Causal Likelihood (PASCAL) classification. RESULTS: Of 2,314 included patients, 827 (35.7%) had PFO. During a median follow-up of 4.4 years, cerebral infarction recurred in 202 (8.7%). In multivariate modified Cox regression analyses, recurrence of infarction did not significantly differ between patients with PFO and those without PFO (hazard ratio [HR] = 0.86, 95% confidence interval [CI] = 0.64-1.17, p = 0.339). Interaction analysis showed a significant effect of PFO in patients aged <65 years (adjusted p for interaction = 0.090). PFO was independently associated with a decreased risk of recurrent infarction in patients younger than 65 years (HR = 0.41, 95% CI = 0.20-0.85, adjusted p = 0.016). Patients with probable PFO-associated stroke on the PASCAL classification had a significantly lower risk of recurrent infarction than those without PFO (HR = 0.31, 95% CI = 0.10-0.97, p = 0.044). INTERPRETATION: Considering the generally low risk of recurrence in PFO-associated stroke, PFO may be the actual cause of stroke in some patients with determined etiologies, especially younger patients or those with PFO features of probable PFO-associated stroke. ANN NEUROL 2022;92:596-606.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Baik M, Shim CY, Gwak SY, et al. Patent Foramen Ovale and Risk of Recurrence in Stroke of Determined Etiology. Ann Neurol. 2022. PMID: 35753038. doi:10.1002/ana.26449

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。